These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19073830)

  • 1. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.
    Cetani F; Lemmi M; Cervia D; Borsari S; Cianferotti L; Pardi E; Ambrogini E; Banti C; Brown EM; Bagnoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2009 Mar; 160(3):481-9. PubMed ID: 19073830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.
    Lia-Baldini AS; Magdelaine C; Nizou A; Airault C; Salles JP; Moulin P; Delemer B; Aitouares M; Funalot B; Sturtz F; Lienhardt-Roussie A
    Eur J Endocrinol; 2013 Feb; 168(2):K27-34. PubMed ID: 23169696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
    Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
    J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.
    Al-Salameh A; Cetani F; Pardi E; Vulpoi C; Pierre P; de Calan L; Guyetant S; Jeunemaitre X; Lecomte P
    Eur J Endocrinol; 2011 Aug; 165(2):359-63. PubMed ID: 21566075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation.
    Cetani F; Pardi E; Borsari S; Tonacchera M; Morabito E; Pinchera A; Marcocci C; Dipollina G
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):199-206. PubMed ID: 12580936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
    Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1.
    Wang X; Lundblad J; Smith SM
    PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia.
    Nanjo K; Nagai S; Shimizu C; Tajima T; Kondo T; Miyoshi H; Yoshioka N; Koike T
    Endocr J; 2010; 57(9):787-92. PubMed ID: 20697181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.
    Nakamura A; Hotsubo T; Kobayashi K; Mochizuki H; Ishizu K; Tajima T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1692-701. PubMed ID: 23966241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.
    Wystrychowski A; Pidasheva S; Canaff L; Chudek J; Kokot F; Wiecek A; Hendy GN
    J Clin Endocrinol Metab; 2005 Feb; 90(2):864-70. PubMed ID: 15572418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
    Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly.
    Pidasheva S; Grant M; Canaff L; Ercan O; Kumar U; Hendy GN
    Hum Mol Genet; 2006 Jul; 15(14):2200-9. PubMed ID: 16740594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.
    Lin CM; Ding YX; Huang SM; Chen YC; Lee HJ; Sung CC; Lin SH
    Front Endocrinol (Lausanne); 2024; 15():1291160. PubMed ID: 38487341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.